Advertisement
CYTK vs NAGE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Buy and NAGE is a Buy.
CYTK's Stochastic Oscillator is staying in oversold zone for 3 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CYTK's RSI Indicator exited the oversold zone, 17 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for CYTK just turned positive on October 13, 2026. Looking at past instances where CYTK's MACD turned positive, the stock continued to rise in 44 of 57 cases over the following month. The odds of a continued upward trend are 77%.
Following a +3.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYTK advanced for three days, in 215 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
CYTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CYTK as a result. In 78 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The 50-day moving average for CYTK moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for CYTK entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. CYTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-49.107) is normal, around the industry mean (3.151). P/E Ratio (-8.488) is within average values for comparable stocks, (-1.051). CYTK's Projected Growth (PEG Ratio) (82.230) is slightly higher than the industry average of (9.059). Dividend Yield (0.000) settles around the average of (127.720) among similar stocks. P/S Ratio (128.205) is also within normal values, averaging (439.237).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
NAGE's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for NAGE turned positive on October 27, 2026. Looking at past instances where NAGE's MACD turned positive, the stock continued to rise in 41 of 50 cases over the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NAGE's RSI Indicator exited the oversold zone, 27 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 73 cases where NAGE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on NAGE as a result. In 72 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
Following a +4.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where NAGE advanced for three days, in 188 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
NAGE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAGE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for NAGE entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.435) is normal, around the industry mean (1.736). P/E Ratio (12.700) is within average values for comparable stocks, (6.461). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.056) among similar stocks. P/S Ratio (1.976) is also within normal values, averaging (4.925).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. NAGE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NAGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
CYTK | NAGE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 75 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 77 | 100 | |
SMR RATING 1..100 | 100 | 45 | |
PRICE GROWTH RATING 1..100 | 61 | 85 | |
P/E GROWTH RATING 1..100 | 20 | 93 | |
SEASONALITY SCORE 1..100 | 50 | 9 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NAGE's Valuation (62) in the Chemicals Specialty industry is in the same range as CYTK (93) in the Biotechnology industry. This means that NAGE’s stock grew similarly to CYTK’s over the last 12 months.
CYTK's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as NAGE (100) in the Chemicals Specialty industry. This means that CYTK’s stock grew similarly to NAGE’s over the last 12 months.
NAGE's SMR Rating (45) in the Chemicals Specialty industry is somewhat better than the same rating for CYTK (100) in the Biotechnology industry. This means that NAGE’s stock grew somewhat faster than CYTK’s over the last 12 months.
CYTK's Price Growth Rating (61) in the Biotechnology industry is in the same range as NAGE (85) in the Chemicals Specialty industry. This means that CYTK’s stock grew similarly to NAGE’s over the last 12 months.
CYTK's P/E Growth Rating (20) in the Biotechnology industry is significantly better than the same rating for NAGE (93) in the Chemicals Specialty industry. This means that CYTK’s stock grew significantly faster than NAGE’s over the last 12 months.
| CYTK | NAGE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 74% |
| Momentum ODDS (%) | 1 day ago 77% | 1 day ago 73% |
| MACD ODDS (%) | 1 day ago 77% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 78% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 77% | 1 day ago 85% |
| Advances ODDS (%) | 9 days ago 73% | 1 day ago 75% |
| Declines ODDS (%) | 3 days ago 78% | 15 days ago 83% |
| BollingerBands ODDS (%) | 1 day ago 73% | 1 day ago 76% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 81% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CYTK’s FA Score shows that 1 FA rating(s) are green while NAGE’s FA Score has 0 green FA rating(s).
- CYTK’s FA Score: 1 green, 4 red.
- NAGE’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CYTK’s TA Score shows that 5 TA indicator(s) are bullish while NAGE’s TA Score has 6 bullish TA indicator(s).
- CYTK’s TA Score: 5 bullish, 4 bearish.
- NAGE’s TA Score: 6 bullish, 2 bearish.
Price Growth
CYTK (@Biotechnology) experienced а -2.51% price change this week, while NAGE (@Food: Major Diversified) price change was +2.83% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -10.85%, and the average quarterly price growth was -12.11%.
The average weekly price growth across all stocks in the @Food: Major Diversified industry was -1.58%. For the same industry, the average monthly price growth was -7.75%, and the average quarterly price growth was -21.11%.
Reported Earning Dates
CYTK is expected to report earnings on Nov 04, 2026.
NAGE is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Biotechnology (+1.47% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Food: Major Diversified (-1.58% weekly)Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.
Advertisement
CYTK and
Correlation & Price change
A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with VRDN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then VRDN could also see price increases.
| Ticker / NAME | Correlation To CYTK | 1D Price Change % | ||
|---|---|---|---|---|
| CYTK | 100% | -0.39% | ||
| VRDN - CYTK | 42% Loosely correlated | +0.75% | ||
| DARE - CYTK | 42% Loosely correlated | +2.56% | ||
| AXSM - CYTK | 41% Loosely correlated | +0.92% | ||
| SRRK - CYTK | 41% Loosely correlated | +1.79% | ||
| BBIO - CYTK | 40% Loosely correlated | +2.09% | ||
More | ||||
NAGE and
Correlation & Price change
A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To NAGE | 1D Price Change % | ||
|---|---|---|---|---|
| NAGE | 100% | +1.60% | ||
| AXON - NAGE | 43% Loosely correlated | -0.63% | ||
| USNA - NAGE | 39% Loosely correlated | +3.91% | ||
| TRDA - NAGE | 38% Loosely correlated | +9.75% | ||
| AMRN - NAGE | 35% Loosely correlated | +6.65% | ||
| CYTK - NAGE | 35% Loosely correlated | -0.39% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SMRF | 20.51 | 0.39 | +1.96% |
| ALPS Nautilus SMR, Nuclear & Technology ETF (SMRF) | |||
| DIVL | 26.04 | -0.02 | -0.08% |
| Madison Dividend Value ETF (DIVL) | |||
| EQAL | 59.04 | -0.05 | -0.08% |
| Invesco Russell 1000 Equal Weight ETF (EQAL) | |||
| AVDV | 106.74 | -0.20 | -0.19% |
| Avantis International Small Cap Value ETF (AVDV) | |||
| TSLR | 19.92 | -0.29 | -1.43% |
| GraniteShares 2x Long TSLA Daily ETF (TSLR) | |||